- Home
- LXEO vs AVBH Comparison
LXEO vs AVBH Comparison
Compare LXEO & AVBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- AVBH
- Stock Information
- Founded
- LXEO 2017
- AVBH 2003
- Country
- LXEO United States
- AVBH United States
- Employees
- LXEO N/A
- AVBH N/A
- Industry
- LXEO
- AVBH
- Sector
- LXEO
- AVBH
- Exchange
- LXEO Nasdaq
- AVBH Nasdaq
- Market Cap
- LXEO 290.5M
- AVBH 282.1M
- IPO Year
- LXEO 2023
- AVBH N/A
- Fundamental
- Price
- LXEO $6.47
- AVBH $25.80
- Analyst Decision
- LXEO Strong Buy
- AVBH Strong Buy
- Analyst Count
- LXEO 7
- AVBH 4
- Target Price
- LXEO $15.29
- AVBH $28.38
- AVG Volume (30 Days)
- LXEO 763.8K
- AVBH 52.9K
- Earning Date
- LXEO 11-12-2025
- AVBH 11-25-2025
- Dividend Yield
- LXEO N/A
- AVBH N/A
- EPS Growth
- LXEO N/A
- AVBH 61.05
- EPS
- LXEO N/A
- AVBH 3.07
- Revenue
- LXEO N/A
- AVBH $82,088,000.00
- Revenue This Year
- LXEO N/A
- AVBH $21.53
- Revenue Next Year
- LXEO N/A
- AVBH $17.90
- P/E Ratio
- LXEO N/A
- AVBH $8.33
- Revenue Growth
- LXEO N/A
- AVBH 21.72
- 52 Week Low
- LXEO $1.45
- AVBH $19.32
- 52 Week High
- LXEO $11.72
- AVBH $26.59
- Technical
- Relative Strength Index (RSI)
- LXEO 67.21
- AVBH N/A
- Support Level
- LXEO $6.33
- AVBH N/A
- Resistance Level
- LXEO $6.90
- AVBH N/A
- Average True Range (ATR)
- LXEO 0.51
- AVBH 0.00
- MACD
- LXEO 0.05
- AVBH 0.00
- Stochastic Oscillator
- LXEO 62.04
- AVBH 0.00
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
About AVBH Avidbank Holdings Inc. Common stock
Avidbank Holdings Inc is a full-service commercial bank. It offers various services such as commercial and industrial lending, venture lending, structured finance, asset-based lending, sponsor finance, real estate construction, and commercial real estate lending.